id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1433-0007,FDA,FDA-2013-E-1433,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T19:30:45Z,,0,0,090000648243b987
FDA-2013-E-1433-0006,FDA,FDA-2013-E-1433,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-08-02T04:00:00Z,2016,8,2016-08-02T04:00:00Z,,2016-08-03T00:39:43Z,,0,0,090000648214fce0
FDA-2013-E-1433-0005,FDA,FDA-2013-E-1433,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-29T02:16:25Z,,0,0,0900006481dd65ac
FDA-2013-E-1433-0004,FDA,FDA-2013-E-1433,"Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,",Notice,Determinations,2015-12-23T05:00:00Z,2015,12,2015-12-23T05:00:00Z,2016-02-23T04:59:59Z,2015-12-23T14:57:05Z,2015-32247,0,0,0900006481dc9730
FDA-2013-E-1433-0003,FDA,FDA-2013-E-1433,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-01-31T05:00:00Z,2014,1,2014-01-31T05:00:00Z,,2014-01-31T16:10:00Z,,0,0,09000064815397d3
FDA-2013-E-1433-0001,FDA,FDA-2013-E-1433,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-11-14T05:00:00Z,2013,11,2013-11-14T05:00:00Z,,2013-11-14T19:32:16Z,,0,0,090000648147ed5d
FDA-2013-E-1433-0002,FDA,FDA-2013-E-1433,ThromboGenics NV (Fish & Richardson) - Patent Extension Application,Other,Application,2013-11-14T05:00:00Z,2013,11,2013-11-14T05:00:00Z,,2013-11-14T19:32:16Z,,0,0,090000648147ed5f